TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vistin Pharma ASA
Closing information (x1000 SEK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
304,124
|
282,820
|
241,656 |
| Financial expenses |
10,007
|
7,508
|
175,537 |
| Earnings before taxes |
-6,352
|
32,808
|
-118,624 |
| Total assets |
430,499
|
341,610
|
307,288 |
| Current assets |
168,284
|
141,333
|
135,095 |
| Current liabilities |
124,531
|
42,078
|
30,741 |
| Equity capital |
288,888
|
282,775
|
260,027 |
| - share capital |
46,881
|
45,472
|
42,330 |
| Employees (average) |
0
|
0 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
67.1%
|
82.8%
|
84.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-2.1%
|
11.6%
|
-49.1% |
| Return on assets (ROA) |
0.8%
|
11.8%
|
18.5% |
| Current ratio |
135.1%
|
335.9%
|
439.5% |
| Return on equity (ROE) |
-2.2%
|
11.6%
|
-45.6% |
| Change turnover |
12,541
|
23,229
|
23,893 |
| Change turnover % |
4%
|
9%
|
11% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.